title: Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene.
authors.forename: Claudia
authors.initials: C
authors.lastname: Cotellessa
authors.forename: Sergio A
authors.initials: SA
authors.lastname: Cuevas-Covarrubias
authors.forename: Patrizia
authors.initials: P
authors.lastname: Valeri
authors.forename: Maria Concetta
authors.initials: MC
authors.lastname: Fargnoli
authors.forename: Ketty
authors.initials: K
authors.lastname: Peris
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004827:Epilepsy; D020022:Genetic Predisposition to Disease; D006016:Glycolates / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016114:Ichthyosis, X-Linked / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D043266:Steryl-Sulfatase / Q000235:genetics*; D012176:Retinoids
chemical_list: D003879:Dermatologic Agents; D006016:Glycolates; D009539:Nicotinic Acids; D043266:Steryl-Sulfatase; C031149:glycolic acid; C086827:tazarotene; D012176:Retinoids